Early Cardiac Dysfunction in Biopsy-proven Nonalcoholic Fatty Liver Disease
Peter C. JohnsonAnthony CochetRosco GoreStephen A. HarrisonJohn MagulickJames K. AdenAngelo H. Paredes
Abstract
NASH patients had evidence of a higher E/e' ratio than NAFL, and there was a trend towards a significant diastolic dysfunction. Patients with NASH compared to NAFL should be closely monitored for signs and symptoms of cardiac dysfunction.
Metrics
Citation History
Topics
Related Documents
Su1546 - Early Cardiac Dysfunction in Biopsy-Proven Nonalcoholic Fatty Liver Disease (NAFLD)
Peter C. JohnsonAnthony CochetRosco GoreStephen A. HarrisonJohn MagulickJames K. AdenAngelo H. Paredes
Cardiac dysfunction in a cohort of biopsy proven nonalcoholic steatohepatitis in comparison to nonalcoholic fatty liver
Jijo VargheseKrishnadas DevadasNeeraj VinayakumarNibin NahazAtul HareendranTharun Tom OommenBony George
Prevalence of biopsy-proven nonalcoholic fatty liver among patients with gallstone disease
FaisalA AlsaifSarah H. AlqahtaniAmaniM AlsadoonKhalid AlswatA. AbdoMazen HassanainAbdulsalamB AlsharabiGhadeerR AljuhaniHishamM AlkhalidiMohamed S. El-SharkawyMaram AlotaibiFaisalM SanaiWaleedK Al-hamoudi
Association of Biopsy-proven Nonalcoholic Fatty Liver Disease with Obesity and Apolipoproteins
Ömer KurtKadir ÖztürkHakan DemirciAhmet TaşYıldırım KarslıoğluTürker TürkerCafer OzdemirTaner ÖzgürtaşAhmet Uygun